INSULET CORP
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
INSULET CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 640 (as per Q3 2016)no data available
Sector Medical Instruments & Equipmen, HealthcareMedical Instruments & Equipmen, Healthcareno data available
Ticker PODDno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 172535455565
datesClosing price (adj.)
13.10.201760.93
11.10.201760.35
04.10.201756.10
27.09.201757.74
20.09.201757.83
13.09.201758.81
06.09.201758.61
30.08.201757.26
23.08.201757.65
16.08.201754.99
09.08.201753.80
02.08.201750.36
26.07.201753.24
19.07.201749.80
12.07.201750.47
05.07.201752.07
27.06.201749.00
20.06.201747.94
13.06.201744.24
06.06.201742.50
30.05.201741.86
23.05.201742.03
16.05.201740.89
09.05.201739.67
02.05.201743.58
25.04.201743.03
18.04.201740.93
11.04.201742.30
04.04.201742.32
28.03.201742.43
21.03.201742.44
14.03.201744.73
07.03.201744.71
28.02.201743.56
21.02.201746.00
14.02.201742.63
07.02.201743.03
31.01.201741.60
24.01.201741.42
17.01.201743.50
10.01.201741.20
03.01.201737.35
27.12.201637.94
19.12.201638.58
12.12.201637.73
05.12.201635.12
28.11.201635.21
21.11.201637.99
14.11.201634.69
07.11.201635.81
31.10.201637.12
24.10.201640.66
17.10.201639.34
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 60.93n/a
Market Capitalisation
in million USD
 3,499n/a
Enterprise Value
in million USD
 3,546n/a
Common Shares Outstanding
as per Sep 30, 2016
 57,418,432n/a
Preferred Shares Outstanding
as per Sep 30, 2016
 n/a
Average Basic Shares Outstanding
TTM
 57,126,859n/a
Average Diluted Shares Outstanding
TTM
 n/a
Index Membership
n/a
Business Summary
Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 283n/a
Receivables 39n/a
Total Current Assets 362n/a
PP&E 51n/a
Total Assets 453n/a
Accounts Payable 18n/a
Current Debt 1n/a
Total Current Liabilities 54n/a
Long-Term Debt 329n/a
Total Liabilities 388n/a
Total Equity 65n/a
Cash Flow
Depreciation & Amortisation 15n/a
Change in Working Capital -33n/a
Operating Cash Flow -23n/a
Net Change in PP&E and Intangibles -23n/a
Investing Cash Flow -84n/a
Dividends Paid 0n/a
Financing Cash Flow 177n/a
Total Change in Cash 70n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 1.14n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 53.47n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.02n/a
Other Ratios
Current Ratio 666.9%n/a
Liabilities to Equity Ratio 596.2%n/a
Debt to Assets Ratio 72.8%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
66
97
152
211
247
289
324
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-48
-53
-86
-119
-135
-145
-176
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
18
44
67
92
112
143
148
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-78
-78
-109
-128
-142
-156
-209
Selling, General & Administrative
-64
-61
-87
-104
-120
-128
-166
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-13
-17
-22
-24
-22
-28
-43
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
-59
-34
-42
-36
-29
-12
-61
Non-Operating Income (Loss)
-26
-45
-29
0
0
23
0
Interest Expense, net
-13
-23
-15
-16
-17
-15
-13
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-13
-23
-15
16
17
38
13
Pretax Income (Loss), Adjusted
-86
-80
-72
-36
-29
11
-61
Abnormal Gains (Losses)
0
-4
0
0
0
-23
0
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-86
-84
-72
-36
-29
-12
-61
Income Tax (Expense) Benefit, net
0
0
11
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-86
-84
-61
-36
-29
-12
-61
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-86
-84
-61
-36
-29
-12
-61
Minority Interest
0
0
0
0
0
0
0
Net Income
-86
-84
-61
-36
-29
-12
-61
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-86
-84
-61
-36
-29
-12
-61
Remarks
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 26, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
113
94
57
150
151
123
Cash & Cash Equivalents
n/a
113
94
57
150
151
123
Short Term Investments
n/a
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
17
23
33
33
40
43
Accounts Receivable, Net
n/a
17
23
33
33
40
43
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
11
12
15
9
13
12
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
1
4
4
6
4
14
Prepaid Expenses
n/a
1
4
4
6
4
4
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
9
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
Total Current Assets
n/a
142
133
110
198
208
191
Property, Plant & Equipment, Net
n/a
13
19
25
32
37
42
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
1
69
63
57
52
43
Intangible Assets
n/a
0
29
23
18
14
1
Goodwill
n/a
0
38
38
38
38
40
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
2
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
1
3
2
2
0
0
Total Noncurrent Assets
n/a
14
89
88
90
89
84
Total Assets
n/a
156
221
198
288
297
275
Liabilities and owners' equity
Payables & Accruals
n/a
15 14703000
24 24482000
28 28412000
39 38837000
39 39362000
52 51957000
Accounts Payable
n/a
5 4895000
11 11418000
9 9361000
19 19359000
15 14659000
15 15213000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
10 9808000
13 13064000
19 19051000
19 19478000
25 24703000
37 36744000
Short Term Debt
n/a
0 0
0 0
14 14429000
3 2637000
3 3380000
6 5519000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
4 4247000
4 3513000
5 5445000
1 900000
2 1554000
8 7680000
Deferred Revenue
n/a
4 4247000
3 2582000
5 5445000
1 900000
2 1554000
2 2361000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
5 5319000
Miscellaneous Short Term Liabilities
n/a
0 0
1 931000
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
19 18950000
28 27995000
48 48286000
42 42374000
44 44296000
65 65156000
Long Term Debt
n/a
69 69433000
109 108540000
104 103730000
119 119041000
166 166283000
172 171967000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
2 1619000
2 2052000
2 1867000
2 1943000
3 2774000
4 3952000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
2 1619000
2 2052000
2 1867000
2 1943000
3 2774000
4 3952000
Total Noncurrent Liabilities
n/a
71 71052000
111 110592000
106 105597000
121 120984000
169 169057000
176 175919000
Total Liabilities
n/a
90 90002000
139 138587000
154 153883000
163 163358000
213 213353000
241 241075000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
450 450084000
512 512419000
526 525727000
651 651122000
662 661867000
686 686250000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-384 -383853000
-430 -429684000
-482 -481551000
-527 -526525000
-578 -578025000
-652 -651545000
Other Equity
n/a
0 0
0 0
0 0
0 0
0 -13000
-1 -654000
Equity Before Minority Interest
n/a
66 66231000
83 82735000
44 44176000
125 124597000
84 83829000
34 34051000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
66 66231000
83 82735000
44 44176000
125 124597000
84 83829000
34 34051000
Total Liabilities & Equity
n/a
156 156233000
221 221322000
198 198059000
288 287955000
297 297182000
275 275126000
Remarks restated on n/a restated on Feb 28, 2013 n/a restated on Feb 28, 2013 n/a restated on Feb 28, 2014 n/a restated on Feb 26, 2015 n/a restated on Feb 29, 2016 n/a restated on Nov 4, 2016 n/a
Cash Flow StatementCF data quality: 93% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-72
-61
-46
-52
-45
-52
-74
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
5
5
9
11
12
12
16
Non-Cash Items
15
28
9
24
30
59
37
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
2
-7
3
-12
7
-11
8
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-49
-36
-25
-29
3
9
-13
Change in Fixed Assets & Intangibles
-3
-7
-11
-11
-7
-11
-11
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
-38
0
0
0
-5
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-3
-7
-49
-11
-7
-11
-15
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
29
-21
51
0
-3
1
-6
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
94
49
5
5
103
12
8
Increase in Capital Stock
94
49
5
5
103
12
8
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
0
-1
-2
-3
-9
-3
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
124
27
55
3
96
4
0
Net Cash Before Disc. Operations and FX
71
-15
-19
-37
92
1
-28
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
71
-15
-19
-37
92
1
-28
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
71
-15
-19
-37
92
1
-29
Remarks
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 26, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo